ArticleJournal of the European Academy of Dermatology and Venereology : JEADV2025

Recibokibart, an anti-IL-36 receptor monoclonal antibody, for treating generalized pustular psoriasis: Phase 1b trial.

Qiaoxia Qian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.